DNMT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Studies have shown that DNMT1 is overexpressed in APL,22 AML,49,50 ALL,50 MDS, and chronic myelogenous leukemia (CML) patients.49,51 The methylation of CpG islands in promoter regions is often observed in lymphomas.